Phase 4 Pulmonary Hypertension Trial, Recruiting (NCT07322133)

Phase 4 Pulmonary Hypertension Trial, Recruiting NCT07322133 Sponsor: University of California, Davis Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07322133 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Babies who are more than 34 weeks and 6 days past their original due date (adjusted for prematurity) and no more than 28 days old since birth
Babies who need breathing support — such as a breathing machine, or oxygen delivered through a mask or nose tube at a certain flow rate — and require at least 30% extra oxygen
Babies whose heart scan (echocardiogram) shows high blood pressure in the lungs (a condition called pulmonary hypertension)
Babies whose blood pressure remains too low for their stage of development, even after receiving a small amount of fluid through a drip
Babies with certain other conditions may still be considered, including a diaphragm defect (CDH), Down syndrome (trisomy 21), a specific type of brain injury being treated with cooling (HIE on hypothermia), or certain heart findings (PDA, PFO/ASD, or a very small hole in the heart wall) (confirm with trial site)

Who may not be able to join:

Babies born before 32 weeks of pregnancy
Babies with very severe breathing difficulties, where oxygen levels remain critically low despite receiving the highest level of oxygen support for more than 60 minutes
Babies with life-limiting conditions affecting their chromosomes, such as trisomy 13 or trisomy 18
Babies with serious, complex heart defects beyond those specifically listed as permitted (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Deepika Sankaran, MD, UC Davis Health

Phone: 916-734-8672

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07322133

Sponsor: University of California, Davis

Phase: Phase 4

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 916-734-8672

More information: https://clinicaltrials.gov/study/NCT07322133

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Babies who are more than 34 weeks and 6 days past their original due date (adjusted for prematurity) and no more than 28 days old since birth
Babies who need breathing support — such as a breathing machine, or oxygen delivered through a mask or nose tube at a certain flow rate — and require at least 30% extra oxygen
Babies whose heart scan (echocardiogram) shows high blood pressure in the lungs (a condition called pulmonary hypertension)
Babies whose blood pressure remains too low for their stage of development, even after receiving a small amount of fluid through a drip
Babies with certain other conditions may still be considered, including a diaphragm defect (CDH), Down syndrome (trisomy 21), a specific type of brain injury being treated with cooling (HIE on hypothermia), or certain heart findings (PDA, PFO/ASD, or a very small hole in the heart wall) (confirm with trial site)

Who may not be able to join:

Babies born before 32 weeks of pregnancy
Babies with very severe breathing difficulties, where oxygen levels remain critically low despite receiving the highest level of oxygen support for more than 60 minutes
Babies with life-limiting conditions affecting their chromosomes, such as trisomy 13 or trisomy 18
Babies with serious, complex heart defects beyond those specifically listed as permitted (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of California, Davis

Registry

ClinicalTrials.gov

Start date

30 June 2026

Est. completion

30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

SAP/PAP ratio; LV Cardiac output; Oxygenation Indices

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov